Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
VICTOR GROUP HOLDINGS LIMITED	VIG	Australian S.E.	0	0.03 AUD	Stock
SHAOYANG VICTOR HYDRAULICS CO.,LTD	301079	Shenzhen S.E.	2,459,022	12.26 CNY	Stock
VICTOR MINING INDUSTRY GROUP INC.	VMTG	OTC Markets	4,573	0.99 USD	Stock
DEU GEN'0'B28'716		Deutsche Boerse AG	-	86 %	Bond
EMIS DEU 5.0/MAR25		Deutsche Boerse AG	-	- %	Bond
DEPFA DEU 3.125% M		Deutsche Boerse AG	-	- %	Bond
DEPFA DEU 3.125% M	DEP062	Swiss Exchange	-	- %	Bond
GRIFOLS 4.7/OCT28/		Deutsche Boerse AG	-	86.3 %	Bond
ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX AUSSICHTSREICHE NEBENWERTE DEU		Börse Stuttgart	-	114.5 EUR	Certificat
ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX AUSSICHTSREICHE NEBENWERTE DEU	LS9PPJ	Berne S.E.	-	- CHF	Certificat

See all

News (49)

Grifols announces positive topline phase 3 fibrinogen clinical trial results	02-14	AQ
GRIFOLS : Grifols accelerates its governance improvements post the short-seller’s allegations	02-07
Grifols Announces Executive Changes	02-06	CI
Grifols announces changes in governance to separate management from ownership as part of planned strategy	02-06	AQ
Spain's Grifols hires new CEO weeks after damaging short-seller report	02-05	RE
Grifols receives FDA approval for expanded immunoglobulin purification and filling capacity at its North Carolina site	11-14	AQ
Transcript : Grifols, S.A., Q3 2023 Earnings Call, Nov 02, 2023	11-02
Grifols S A : appoints Miguel Louzan Chief Digital Information Officer	23-09-19	PU
Grifols names Dr Jorg Schuttrumpf Chief Scientific Innovation Officer	23-09-05	AQ
Transcript : Grifols, S.A., Q2 2023 Earnings Call, Jul 27, 2023	23-07-27
Grifols highlights the acceleration of its operating performance and reiterates its strong commitment to debt reduction	23-06-19	AQ
Grifols S A : highlights the acceleration of its operating performance and reiterates its strong commitment to debt reduction	23-06-16	PU
Grifols S A : June 16 2023Grifols highlights the acceleration of its operating performance and reiterates its strong commitment to debt reduction	23-06-16	PU
Grifols welcomes Egypt's ambassador to Spain at its plasma processing plant in Parets del Valles	23-06-15	AQ
Grifols S A : First Quarter 2023 – Conference call transcript	23-05-10	PU
GRIFOLS : Upbeat Q1 a much-needed boost to investor confidence	23-05-09
Transcript : Grifols, S.A., Q1 2023 Earnings Call, May 09, 2023	23-05-09
Grifols S A : delivers strong first quarter financials with 23% revenue growth and an Adjusted EBITDA margin above guidance of 21%	23-05-09	PU
Grifols S A : May 9 2023Grifols delivers strong first quarter financials with 23% revenue growth and an Adjusted EBITDA margin above guidance of 21%	23-05-09	PU
Grifols S A : First Quarter 2023 Results earnings release – Press Release	23-05-09	PU
Grifols S A : First Quarter 2023 Results earnings release – Presentation	23-05-09	PU
Grifols S A : realigns management structure to accelerate company performance and simplify its corporate governance	23-05-08	PU
Grifols S A : May 8 2023Grifols realigns management structure to accelerate company performance and simplify its corporate governance	23-05-08	PU
Grifols enters into global collaboration and licensing agreement with Selagine to develop immunoglobulin eye drops to treat dry eye disease	23-03-08	AQ
Grifols S A : Full year 2022 – Conference call transcript	23-03-02	PU
Transcript : Grifols, S.A., 2022 Earnings Call, Feb 28, 2023	23-02-28
Grifols S A : delivers strong 2022 performance and is positioned for sustainable future growth	23-02-28	PU
Grifols S A : February 28 2023Grifols delivers strong 2022 performance and is positioned for sustainable future growth	23-02-28	PU
Grifols S A : Full year 2022 earnings release – Press Release	23-02-28	PU
Grifols S A : First half 2022 earnings release - Press release	22-11-10	PU
Grifols S A : Third Quarter 2022 Business update – Conference call transcript	22-11-09	PU
Transcript : Grifols, S.A., Q3 2022 Earnings Call, Nov 08, 2022	22-11-08
Grifols S A : ’ Biopharma delivers robust 34% operational growth in Q3, driving revenues to EUR 4,351m in the first nine months of 2022	22-11-08	PU
Grifols S A : November 8 2022Grifols’ Biopharma delivers robust 34% operational growth in Q3, driving revenues to EUR 4,351m in the first nine months of 2022	22-11-08	PU
Grifols S A : Third quarter earnings release	22-11-08	PU
Victor Grifols Roura decides to retire as Chairperson; Grifols appoints private equity veteran Steven F. Mayer as Executive Chairperson	22-10-03	PR
Grifols : Extends Commitment to World Federation of Hemophilia Humanitarian Aid Program to 2030	21-04-15	PR
Grifols S A : delivers first manufactured batches of its anti-SARS-CoV-2 hyperimmune globulin for clinical trials	20-07-28	PR
Grifols : July 28, 2020Grifols delivers first manufactured batches of its anti-SARS-CoV-2 hyperimmune globulin for clinical trials	20-07-28	PU
Grifols : May 5, 2020 Grifols completes development of very high sensitivity molecular test to detect SARS-CoV-2 virus Read more	20-05-06	PU
Grifols : completes development of very high sensitivity molecular test to detect SARS-CoV-2 virus	20-05-05	AQ
Grifols : S.A. annual accounts, auditor's report and directors' report for the financial year 2019	20-02-27	PU
Grifols : and Mondragon sign technology collaboration agreement	19-09-06	PU
Grifols : selected to build its first intravenous solutions manufacturing line in Africa	19-07-03	PU
Grifols : donations of blood clotting factor helping people with hemophilia globally	19-04-15	PR

12NextSee all

Companies (18)

GRIFOLS, S.A. 6 626 M $

Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - ...

GRIFOLS, S.A. 6 626 M $

SUPERIOR RESOURCES LIMITED 12 M $

Superior Resources Limited is an Australia-based exploration company. The Company holds a portfolio of Tier 1 potential exploration projects in North Queensland prospective for copper, gold, nickel-platinum group element, zinc-lead-silver, rare earth elem ...

DT CAPITAL LIMITED 21 M $

DT CAPITAL LIMITED is a Hong Kong-based investment holding company principally engaged in securities investment. The investment objective of the Company is to invest in listed equity securities and unlisted debt securities for earnings growth and capital ...

SHAOYANG VICTOR HYDRAULICS CO.,LTD 182 M $

Shaoyang Victor Hydraulics Co Ltd is a China-based company mainly engaged in the design, research and development (R&D), production and sales of hydraulic piston pump, hydraulic cylinder and hydraulic system. The Company is also engaged in professional te ...

DANA INCORPORATED 2 029 M $

Dana Incorporated is engaged in providing power-conveyance and energy-management solutions for vehicles and machinery. The Company's portfolio improves the efficiency, performance, and sustainability of light vehicles, commercial vehicles, and off-highway ...

VICTOR GROUP HOLDINGS LIMITED 11 M $

Victor Group Holdings Limited is an Australia-based company that is engaged in providing Software-as-a-Service (SaaS) and Platform-as-a-service (PaaS) solutions. It is also building and operating cloud-based platforms for education and remote office appli ...

WINNERGY MEDICAL 26 M $

Winnergy Medical Public Company Limited is a Thailand-based company, which is engaged in the distribution of medical and diagnostics equipment. The Company imports high technology medical and diagnostic products from around the world to help improve the l ...

12Next

Insiders

Victor Grifols Deu

Victor Grifols Deu is currently the Chairman of Aigües Minerals de Vilajuïga SA since 2018.
He previously worked as a Director at Grifols Escrow Issuer SA.

Victor Grifols Deu

Currently, Victor Grifols Deu occupies the position of Joint Chief Executive Officer & Executive Director at Grifols SA. Mr. Deu is also on the board of Araclon Biotech SL. He received an undergraduate degree from Institut Químic De Sarrià and an MBA from UCD Michael Smurfit Graduate School of Business.

Lucas Victor Grifols

Víctor Grifols Roura

Víctor Grifols Roura holds the position of Non-Executive Chairman for Grifols SA and Chairman at Instituto Grifols SA and Chairman & Chief Executive Officer at Arrahona Optimus SL (both are subsidiaries of Grifols SA). He is also on the board of Scranton Enterprises BV, Grifols USA, Inc. and Criteria Caixa SA. He received an undergraduate degree from the University of Barcelona.

Frank Le Deu

Xavier Deu

Mr. Xavier Deu is Chief Marketing Officer at Carlisle Management Co. SCA.
Mr. Deu created Grupo Misame, a Spanish firm that developed a new approach to allow the dual ownership of residential real state by families and investors, and allow for securitization of such mortgage related product.
Under Grupo Misame, developed several consulting projects among them for the Government of Andorra and the Government of Catalonia in Spain.
Prior to Grupo Misame developed several consulting tasks, among them as Consultant for the Homebuilders Association of Andorra, the Ministry of Economics in Andorra, in de development and implementation of future economic laws.
In the US, worked at The Riskmetrics Group, spin-off of J.P.
Morgan, in the sales & Marketing department.
Before joining Riskmetrics worked as a trader for several years and before developed several tasks on distribution for financial products for several firms in the US.
He holds a degree in Economics from the University Autonomous of Barcelona and a Masters in International Finance and Economics from Brandeis University.

No results for this search

Stock Market
Advanced search
Victor Grifols Deu